| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |